We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXLS icon
126
EXL Service
EXLS
$4.24B
$721K 0.19%
61,835
+4,960
+9% +$55.6K
FONR
127
DELISTED
Fonar
FONR
$719K 0.19%
23,571
+2,494
+12% +$70.4K
PFPT
128
DELISTED
Proofpoint, Inc.
PFPT
$717K 0.19%
+8,220
New +$731K
TWX
129
DELISTED
Time Warner Inc
TWX
$709K 0.19%
6,919
+775
+13% +$78.6K
MDT icon
130
Medtronic
MDT
$107B
$708K 0.19%
9,101
+475
+6% +$39.4K
ELV icon
131
Elevance Health
ELV
$82.1B
$707K 0.19%
3,726
+470
+14% +$89.5K
WY icon
132
Weyerhaeuser
WY
$17.3B
$706K 0.19%
20,761
+8,451
+69% +$278K
MAS icon
133
Masco
MAS
$15.9B
$698K 0.19%
17,886
+1,299
+8% +$49K
CMT icon
134
Core Molding Technologies
CMT
$213M
$692K 0.18%
31,553
+2,978
+10% +$62.5K
UNM icon
135
Unum
UNM
$13.8B
$691K 0.18%
13,506
+1,375
+11% +$67.1K
HXL icon
136
Hexcel
HXL
$8.24B
$676K 0.18%
11,777
+1,269
+12% +$68.4K
IMPV
137
DELISTED
Imperva, Inc.
IMPV
$675K 0.18%
+15,550
New +$710K
IBM icon
138
IBM
IBM
$203B
$671K 0.18%
4,841
+434
+10% +$60.5K
HF
139
DELISTED
HFF Inc.
HF
$668K 0.18%
16,893
+1,618
+11% +$59.6K
CTWS
140
DELISTED
Connecticut Water Service Inc
CTWS
$666K 0.18%
+11,235
New +$632K
PFBC icon
141
Preferred Bank
PFBC
$1.23B
$659K 0.18%
10,921
+1,695
+18% +$93.4K
MULE
142
DELISTED
MuleSoft, Inc.
MULE
$655K 0.17%
+32,519
New +$724K
MPC icon
143
Marathon Petroleum
MPC
$90.8B
$652K 0.17%
11,631
+615
+6% +$33K
BNS icon
144
Scotiabank
BNS
$106B
$647K 0.17%
10,072
+866
+9% +$53.8K
AMWD
145
DELISTED
American Woodmark
AMWD
$645K 0.17%
6,701
+634
+10% +$58.7K
WPC icon
146
W.P. Carey
WPC
$17B
$633K 0.17%
9,597
-145
-1% -$9.64K
GE icon
147
GE Aerospace
GE
$365B
$632K 0.17%
5,458
-117
-2% -$14.1K
GPK icon
148
Graphic Packaging
GPK
$3.27B
$628K 0.17%
45,043
+2,164
+5% +$29K
VLO icon
149
Valero Energy
VLO
$90.4B
$622K 0.17%
8,082
+242
+3% +$16.7K
LABL
150
DELISTED
Multi-Color Corp
LABL
$622K 0.17%
7,589
+914
+14% +$73K
4 5
6
7 8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.